Trisomy 18 syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:3380Q91.0Q91.1Q91.2
Who is this for?
Show terms as
25Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Trisomy 18 syndrome, also known as Edwards syndrome, is a chromosomal disorder caused by the presence of an extra copy of chromosome 18. It is the second most common autosomal trisomy after Down syndrome (trisomy 21). The condition can occur as full trisomy 18 (most common, accounting for approximately 94% of cases), mosaic trisomy 18, or partial trisomy 18. The ICD-10 codes reflect these subtypes: Q91.0 and Q91.1 for full trisomy 18 (nondisjunction and mosaicism, respectively), Q91.2 for translocation forms, and Q91.3 for unspecified trisomy 18. Trisomy 18 affects virtually every organ system in the body. Key clinical features include severe intrauterine growth restriction, a distinctive craniofacial appearance with a prominent occiput, micrognathia (small jaw), and low-set malformed ears. Characteristic hand positioning with overlapping fingers (clenched fists with the index finger overlapping the third and the fifth finger overlapping the fourth) is a hallmark finding. Congenital heart defects are present in over 90% of affected individuals, most commonly ventricular septal defects and polyvalvular disease. Other features include rocker-bottom feet, short sternum, renal malformations, omphalocele, and severe intellectual disability. Many affected pregnancies result in miscarriage or stillbirth. The prognosis for full trisomy 18 is very poor, with median survival of approximately 5 to 15 days. Approximately 50% of affected infants do not survive beyond the first week of life, and only 5–10% survive beyond the first year. Individuals with mosaic trisomy 18 may have a milder phenotype and longer survival. There is no cure for trisomy 18. Management is supportive and individualized, focusing on comfort care, nutritional support, and treatment of specific complications such as cardiac defects when appropriate. Palliative care discussions are an important component of management. Advanced maternal age is a recognized risk factor, and prenatal diagnosis is possible through screening tests and confirmatory procedures such as amniocentesis or chorionic villus sampling.

Also known as:

Clinical phenotype terms— hover any for plain English:

Narrow pelvis boneHP:0003275Deviation of fingerHP:0004097
Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Trisomy 18 syndrome.

View clinical trials →

No actively recruiting trials found for Trisomy 18 syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Trisomy 18 syndrome community →

Specialists

25 foundView all specialists →
GP
Glenn E Palomaki, PhD
Specialist
PI on 2 active trials
MM
Mary Norton, MD
Specialist
PI on 3 active trials
AM
Amy J Sehnert, MD
PALO ALTO, CA
Specialist
PI on 3 active trials1 Trisomy 18 syndrome publication
AM
Allan Bombard, MD
SAN DIEGO, CA
Specialist
PI on 1 active trial1 Trisomy 18 syndrome publication
TM
Thomas J Garite, MD
ORANGE, CA
Specialist
PI on 2 active trials
PM
Peer Dar, MD
BRONX, NY
Specialist
PI on 2 active trials
AM
Asma Khalil, MBBS
Specialist
PI on 1 active trial
AM
Allan T Bombard, MD
SAN DIEGO, CA
Specialist
PI on 1 active trial1 Trisomy 18 syndrome publication
SR
Stephen Robson
Specialist
PI on 1 active trial14 Trisomy 18 syndrome publications
RM
Richard Porreco, MD
DENVER, CO
Specialist
PI on 3 active trials
RM
Rajeevi Madankumar, MD
NEW HYDE PARK, NY
Specialist
PI on 1 active trial
FF
Francois Rousseau, MD MSc FRCPC
Specialist
PI on 1 active trial
JM
Joanne Stone, MD
Specialist
PI on 1 active trial
BM
Brian Kirshon, MD
HOUSTON, TX
Specialist
PI on 1 active trial
MP
Matthew Rabinowitz, PhD
LORETTO, PA
Specialist
PI on 2 active trials
AP
Alexandra Benachi, MD, PhDi
Specialist
PI on 1 active trial
RM
Robert Carpenter, MD
Specialist
PI on 1 active trial
SF
Sylvie Langlois, MD FRCPC
Specialist
PI on 1 active trial
KP
Karl-Oliver Kagan, Prof.
Specialist
PI on 1 active trial
EP
Errol Norwitz, MD, PhD
NEW HAVEN, CT
Specialist
PI on 1 active trial
RM
Robert Lamar Parker, MD
Specialist
PI on 1 active trial
ZP
Zachary Demko, PhD
FRANKLIN, TN
Specialist
PI on 1 active trial
ZP
Zach Demko, PhD
FRANKLIN, TN
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Trisomy 18 syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Trisomy 18 syndromeForum →

No community posts yet. Be the first to share your experience with Trisomy 18 syndrome.

Start the conversation →

Latest news about Trisomy 18 syndrome

No recent news articles for Trisomy 18 syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Trisomy 18 syndrome

What is Trisomy 18 syndrome?

Trisomy 18 syndrome, also known as Edwards syndrome, is a chromosomal disorder caused by the presence of an extra copy of chromosome 18. It is the second most common autosomal trisomy after Down syndrome (trisomy 21). The condition can occur as full trisomy 18 (most common, accounting for approximately 94% of cases), mosaic trisomy 18, or partial trisomy 18. The ICD-10 codes reflect these subtypes: Q91.0 and Q91.1 for full trisomy 18 (nondisjunction and mosaicism, respectively), Q91.2 for translocation forms, and Q91.3 for unspecified trisomy 18. Trisomy 18 affects virtually every organ syste

How is Trisomy 18 syndrome inherited?

Trisomy 18 syndrome follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Trisomy 18 syndrome typically begin?

Typical onset of Trisomy 18 syndrome is neonatal. Age of onset can vary across affected individuals.

Which specialists treat Trisomy 18 syndrome?

25 specialists and care centers treating Trisomy 18 syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.